Navigation Links
Cardinal Rigali Criticizes Final NIH Guidelines for Destructive Stem Cell Research
Date:7/7/2009

WASHINGTON, July 7 /PRNewswire-USNewswire/ -- Cardinal Justin Rigali, Chairman of the U.S. Catholic Bishops' Committee on Pro-Life Activities, reacted today to final guidelines for human embryonic stem cell research issued yesterday by the National Institutes of Health (NIH). The text of his statement follows:

"In April I criticized the NIH's draft guidelines for destructive embryonic stem cell research, saying that under these guidelines 'federal tax dollars will be used to encourage destruction of living embryonic human beings for stem cell research - including human beings who otherwise would have survived and been born.'

"The final guidelines issued yesterday are even broader. Parents who are asked to consider having their embryonic children destroyed for research will not even have to be informed about all their other options - only about the options that happen to be available at their particular fertility clinic. Moreover, under the final guidelines, stem cell lines that existed previously or that are produced in foreign countries may be made eligible for federally funded research even if they were obtained in ways that violate one or more of the NIH's own informed consent requirements.

"The comments of tens of thousands of Americans opposing the destruction of innocent human life for stem cell research were simply ignored in this process. Even comments filed by the Catholic bishops' conference and others against specific abuses in the draft guidelines were not addressed. For example, federally funded researchers will be allowed to insert human embryonic stem cells into the embryos of animal species other than primates; federal grants will be available even to researchers who themselves destroyed human embryos to obtain the stem cells for their research. Existing federal law against funding research in which human embryos are harmed or destroyed is not given due respect here.

"This debate now shifts to Congress, where some members have said even this policy does not go far enough in treating some human beings as objects to be created, manipulated and destroyed for others' use. I hope Americans concerned about this issue will write to their elected representatives, urging them not to codify or further expand this unethical policy."

For more information about the USCCB's "Oppose Destructive Stem Cell Research" campaign, visit www.usccb.org/stemcellcampaign. Cardinal Rigali's April 21 statement on the draft guidelines is at www.usccb.org/comm/archives/2009/09-087.shtml. The USCCB's official comment letter of May 22 is at www.usccb.org/prolife/NIHcomments.pdf.


'/>"/>
SOURCE U.S. Conference of Catholic Bishops Secretariat for Pro-Life Activities
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardinal Health Reaffirms Fiscal 2008 EPS Guidance, Updates Segment Profit Outlook
2. Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years
3. Cardinal Health To Announce First-Quarter Results on November 5
4. Cardinal Health Announces Sector Management Change
5. Cardinal Health Reports First Quarter Results
6. Cardinal Health, Sentry Data Systems Introduce New Technology to Help Health Care Providers More Cost-Efficiently Care for Underserved
7. Cardinal Health Receives DEA Order to Temporarily Cease Distribution of Controlled Substances from Auburn, Wash. Facility
8. Cardinal Health Foundation Grants $537,000 to Rural, Public Hospitals in Support of IHIS 5 Million Lives Campaign
9. Cardinal Health to Cease Distribution of Controlled Substances from Florida Facility
10. Cardinal Health to Announce Second-Quarter Results on January 29
11. Cardinal Health Taps Teva Executive George Barrett to Lead Healthcare Supply Chain Services Sector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... ... February 17, 2017 , ... For the first time, International ... the exhibit floor for the 2017 HIMSS Conference & Exhibition at ... 2017, more than 40,000 healthcare industry professionals are expected at the conference, where ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's ... goals for each and every seminar, session and class she offers. At ... brainwave tools which help energize creativity, focus mental functions, enhance athletic focus and ...
(Date:2/17/2017)... ... February 17, 2017 , ... ... named a finalist in the 8th Annual DecisionHealth Platinum Awards in recognition of ... Qualis Health’s work is recognized across multiple award categories, highlighting four of the ...
(Date:2/17/2017)... ... February 17, 2017 , ... Program will ... Trinity Health and the U.S. Soccer Foundation announced today that they have awarded ... Soccer for Success, the Foundation’s soccer mentoring program, teaches kids the fundamentals of ...
(Date:2/17/2017)... ... February 17, 2017 , ... Pharmica Consulting ... on all facets of clinical trial planning and management. Pharmica discussed the importance ... more. In addition, attendees stopping by Pharmica’s booth were able to demo its ...
Breaking Medicine News(10 mins):
(Date:2/16/2017)... 16, 2017  Aralez Pharmaceuticals Inc. (NASDAQ: ... today announced that executive management will participate in the ... February 22-23, 2017. Adrian Adams , Chief Executive ... 1:35 p.m. local time on Wednesday, February 22, 2017. ... the event may be accessed from the Investors section ...
(Date:2/16/2017)... REDWOOD CITY, Calif. , Feb. 16, 2017 ... ), a specialty pharmaceutical company focused on the ... treatment of moderate-to-severe acute pain, announced that ... executive officer and a member of the company,s ... Mr. Angotti brings over two decades of experience ...
(Date:2/16/2017)... 16, 2017 Research and Markets has announced ... Analysis & Trends - Function, Application, Cancer Type, Technology - Forecast ... ... Market is poised to grow at a CAGR of around 28.6% ... Some of the prominent trends that the ...
Breaking Medicine Technology: